Jillian B. Thomsen, SVP & Chief Accounting Officer at NEKTAR THERAPEUTICS (NKTR), sold 3,616 shares at $42.39 ($153K) on 2019-02-19, disclosed to the SEC on 2019-02-21.
Seasonal sale ($153k) by SVP & Chief Accounting Officer — this insider has traded NKTR in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.39 | 1,808 | $77K | 50.0% |
| 2 | $42.39 | 1,808 | $77K | 50.0% |
| Total | $42.39 avg | 3,616 | $153K | 100% |
| Filing → |
| NKTR | SELL | 2022-08-17 | $10K | — | Filing → |
| NKTR | SELL | 2022-05-17 | $23K | — | Filing → |
| NKTR | SELL | 2022-02-18 | $26K | — | Filing → |